维升药业IPO火爆逾70倍超购:基石阵容豪华

格隆汇
20 Mar

维升药业股份有限公司(简称“维升药业”,代码02561)发行价格为每股68.80港币,基础融资规模1亿美元(含扩大发行规模15%),绿鞋规模1500万美元(基础发行规模的15%),将于3月21日正式上市。据悉,招股期截止时,预计其公开发售部分获得近70倍超额认购,国际发售部分同时获得超额申购。维升药业此次IPO引入了5名基石投资者,包括安科生物、苏州工业园区产业投资基金、Vivo Capital、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10